(Q53854824)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Dario Sorrentino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Claudio Avellini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Carlo Alberto Beltrami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Ester Zearo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

11 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Colorectal Disease

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

276-281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00384-005-0739-0

12 January 2020

exact match

0 references

cites work

IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle

1 reference

12 December 2020

Medical therapy for Crohn's disease strictures

1 reference

12 December 2020

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Cytokines increase proliferation of human intestinal smooth muscle cells: possible role in inflammation-induced stricture formation

1 reference

12 December 2020

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

12 December 2020

Contribution of morphology for the comprehension of mechanisms of fibrosis in inflammatory enterocolitis

1 reference

12 December 2020

Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease

1 reference

12 December 2020

Review article: maintenance treatment of Crohn's disease

1 reference

12 December 2020

Collagen content and types in the intestinal strictures of Crohn's disease

1 reference

12 December 2020

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

12 December 2020

Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003.

1 reference

12 December 2020

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

1 reference

12 December 2020

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

1 reference

12 December 2020

Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models

1 reference

12 December 2020

Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype

1 reference

12 December 2020

Can we influence fibrosis in Crohn's disease?

1 reference

12 December 2020

Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation

1 reference

12 December 2020

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

1 reference

12 December 2020

Cytokines and inflammatory bowel disease

1 reference

12 December 2020

Genetic variation in DLG5 is associated with inflammatory bowel disease

1 reference

12 December 2020

Mechanisms of infliximab: the reverse side of a drug effect

1 reference

12 December 2020

Endoscopic treatment of stenosis in recurrent Crohn's disease with balloon dilation combined with local corticosteroid injection

1 reference

12 December 2020

Benign and malignant colorectal strictures in ulcerative colitis

1 reference

12 December 2020

Inflammatory bowel disease

1 reference

12 December 2020

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

1 reference

12 December 2020

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

12 December 2020

10.1007/S00384-005-0739-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15951989%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference